• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CASHEL SMART CONTROL, ILIAC 6X60ML; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CASHEL SMART CONTROL, ILIAC 6X60ML; STENT, ILIAC Back to Search Results
Catalog Number C06060ML
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Multiple Organ Failure (3261)
Event Date 02/06/2017
Event Type  Death  
Manufacturer Narrative
As reported by the smart pms for sfa study, approximately forty months post implantation of a smart (smart control, iliac 6x60ml) self¿expanding stents (ses) on the superficial femoral artery (sfa), the patient went to a different hospital for dialysis.However, during dialysis, the patient expired.The cause of death was multiple organ failure.None of these events were relevant to the index procedure or the cordis product.Originally, the patient had been implanted with a smart stent that was deployed in the target lesion without any issue.The device was not returned for evaluation.A review of the manufacturing documentation associated with lot 15647816 presented no issues during the manufacturing process that can be related to the reported event.Death is a known potential adverse event associated with stent implantation procedures and is listed in the instructions for use (ifu), which are not intended as mitigation, as such.All products undergo a 100% inspection prior to release for marketing.Intra-arterial stent placement is a treatment of the disease process and it not a preventive or cure for the progression of symptoms of atherosclerotic artery disease.A review of the available information does not allow for an exact determination of causal factors.However, based on the information provided, the root cause for the reported events was attributed to multiple organ failure.Given the limited information available for review at this time, there is nothing to suggest that the reported event is related to the design and manufacturing process of the device.Therefore no corrective action will be taken.Should additional information become available, the file will be updated accordingly.
 
Event Description
As reported by the smart pms for sfa study, approximately forty months post implantation of a smart (smart control, iliac 6x60ml) self¿expanding stents (ses) on the superficial femoral artery, the patient went to a different hospital for dialysis.However, during dialysis, the patient expired.The cause of death was multiple organ failure.None of these events were relevant to the index procedure or the cordis product.A smart stents was deployed in the target lesion without any issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMART CONTROL, ILIAC 6X60ML
Type of Device
STENT, ILIAC
Manufacturer (Section D)
CORDIS CASHEL
cahir road
cashel, co. tipperary
EI 
Manufacturer (Section G)
CORDIS CASHEL
cahir road
cashel, co. tipperary
EI  
Manufacturer Contact
karla castro
14201 nw 60th ave
miami lakes, FL 33014
MDR Report Key6902014
MDR Text Key87672709
Report Number9616099-2017-01473
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P020036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation Health Professional
Type of Report Initial
Report Date 09/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2014
Device Catalogue NumberC06060ML
Device Lot Number15647816
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/12/2017
Initial Date FDA Received09/28/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured07/12/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDEWIRE: 0.014; GUIDING SHEATH: 6FR; SHEATH INTRODUCER: 6FR
Patient Outcome(s) Death;
Patient Age76 YR
Patient Weight70
-
-